Paper36980805
Prevention of Inflammation-Driven Colon Carcinogenesis in Human MUC1 Transgenic Mice by Vaccination with MUC1 DNA and Dendritic Cells.
Murwanti R and 5 others. Cancers (Basel), 2023. Cited by 6 papers, by iCite.
Cite this record
ConductScience Library. Prevention of Inflammation-Driven Colon Carcinogenesis in Human MUC1 Transgenic Mice by Vaccination with MUC1 DNA and Dendritic Cells. Papers, record 36980805. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36980805
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Prevention of Inflammation-Driven Colon Carcinogenesis in Human MUC1 Transgenic Mice by Vaccination with MUC1 DNA and Dendritic Cells.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants6
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| JP23689009 | Japan Society for the Promotion of Science | PubMed | ||
| JP21790144 | Japan Society for the Promotion of Science | PubMed | ||
| JP20K07163 | Japan Society for the Promotion of Science | PubMed | ||
| JP19790118 | Japan Society for the Promotion of Science | PubMed | ||
| JP21390018 | Japan Society for the Promotion of Science | PubMed | ||
| JP25293011 | Japan Society for the Promotion of Science | PubMed |
Source PubMed
References62
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 7905449 | MUC1 mucin expression as a marker of progression and metastasis of human colorectal carcinoma. | Gastroenterology | 1994 | https://conductscience.org/library/papers/7905449 | PubMed |
| 2 | 19426130 | Tumor-associated MUC1 glycopeptide epitopes are not subject to self-tolerance and improve responses to MUC1 peptide epitopes in MUC1 transgenic mice. | Biol Chem | 2009 | https://conductscience.org/library/papers/19426130 | PubMed |
| 3 | 19025220 | Aberrant expression of MUC1 mucin in pediatric inflammatory bowel disease. | Pediatr Dev Pathol | 2010 | https://conductscience.org/library/papers/19025220 | PubMed |
| 4 | 14611673 | A novel inflammation-related mouse colon carcinogenesis model induced by azoxymethane and dextran sodium sulfate. | Cancer Sci | 2003 | https://conductscience.org/library/papers/14611673 | PubMed |
| 5 | 9143702 | DNA vaccines. | Annu Rev Immunol | 1997 | https://conductscience.org/library/papers/9143702 | PubMed |
| 6 | 9443411 | Tolerance and immunity to MUC1 in a human MUC1 transgenic murine model. | Cancer Res | 1998 | https://conductscience.org/library/papers/9443411 | PubMed |
| 7 | 16776849 | Pilot phase III immunotherapy study in early-stage breast cancer patients using oxidized mannan-MUC1 [ISRCTN71711835]. | Breast Cancer Res | 2006 | https://conductscience.org/library/papers/16776849 | PubMed |
| 8 | 31467405 | Dendritic cells in cancer immunology and immunotherapy. | Nat Rev Immunol | 2020 | https://conductscience.org/library/papers/31467405 | PubMed |
| 9 | 10837079 | DNA vaccines: immunology, application, and optimization*. | Annu Rev Immunol | 2000 | https://conductscience.org/library/papers/10837079 | PubMed |
| 10 | 24188672 | Up to 15-year clinical follow-up of a pilot Phase III immunotherapy study in stage II breast cancer patients using oxidized mannan-MUC1. | Immunotherapy | 2013 | https://conductscience.org/library/papers/24188672 | PubMed |
| 11 | 9200432 | The dominant role of bone marrow-derived cells in CTL induction following plasmid DNA immunization at different sites. | J Immunol | 1997 | https://conductscience.org/library/papers/9200432 | PubMed |
| 12 | 1195058 | Squamous metaplasia in the healing of chronic colonic ulcers of the rat. | J Pathol | 1975 | https://conductscience.org/library/papers/1195058 | PubMed |
| 13 | 29193802 | A Synthetic MUC1 Anticancer Vaccine Containing Mannose Ligands for Targeting Macrophages and Dendritic Cells. | ChemMedChem | 2018 | https://conductscience.org/library/papers/29193802 | PubMed |
| 14 | 19109152 | Progression of pancreatic adenocarcinoma is significantly impeded with a combination of vaccine and COX-2 inhibition. | J Immunol | 2009 | https://conductscience.org/library/papers/19109152 | PubMed |
| 15 | 9521319 | Dendritic cells and the control of immunity. | Nature | 1998 | https://conductscience.org/library/papers/9521319 | PubMed |
| 16 | 23028615 | Local effects of regulatory T cells in MUC1 transgenic mice potentiate growth of MUC1 expressing tumor cells in vivo. | PLoS One | 2012 | https://conductscience.org/library/papers/23028615 | PubMed |
| 17 | 23248097 | MUC1 vaccine for individuals with advanced adenoma of the colon: a cancer immunoprevention feasibility study. | Cancer Prev Res (Phila) | 2013 | https://conductscience.org/library/papers/23248097 | PubMed |
| 18 | 11206842 | Absence of correlation of MUC1 expression to malignant behavior of renal cell carcinoma in experimental systems. | Clin Exp Metastasis | 2000 | https://conductscience.org/library/papers/11206842 | PubMed |
| 19 | 8813954 | Significance of MUC1 and MUC2 mucin expression in colorectal cancer. | J Clin Pathol | 1996 | https://conductscience.org/library/papers/8813954 | PubMed |
| 20 | 17292519 | Intradermal vaccination of MUC1 transgenic mice with MUC1/IL-18 plasmid DNA suppresses experimental pulmonary metastases. | Vaccine | 2007 | https://conductscience.org/library/papers/17292519 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41681861 | Cancer Prevention Clinical Trials: Advances and Challenges. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/41681861 | PubMed |
| 40211993 | Advanced Technologies for Cancer Immunotherapy: Focus on Gastrointestinal Cancers. | Anticancer Agents Med Chem | 2025 | https://conductscience.org/library/papers/40211993 | PubMed |
| 40154956 | SITC strategic vision: prevention, premalignant immunity, host and environmental factors. | J Immunother Cancer | 2025 | https://conductscience.org/library/papers/40154956 | PubMed |
| 39739658 | Identification of O-glycosylation related genes and subtypes in ulcerative colitis based on machine learning. | PLoS One | 2024 | https://conductscience.org/library/papers/39739658 | PubMed |
| 37886952 | The Potential of Dendritic Cell Subsets in the Development of Personalized Immunotherapy for Cancer Treatment. | Curr Issues Mol Biol | 2023 | https://conductscience.org/library/papers/37886952 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| MUC1 | 4582 | PubTator's text mining | https://conductscience.org/library/genes/4582 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36980805
GET https://conductscience.org/api/papers/v1/36980805/references?page=2